Vis enkel innførsel

dc.contributor.authorSvendsen, Karianne
dc.contributor.authorJacobs Jr., David R.
dc.contributor.authorRøyseth, Ida Tonning
dc.contributor.authorGarstad, Kjersti W.
dc.contributor.authorByfuglien, Marte Gjeitung
dc.contributor.authorGranlund, Linda
dc.contributor.authorMørch-Reiersen, Lisa T.
dc.contributor.authorTelle-Hansen, Vibeke
dc.contributor.authorRetterstøl, Kjetil
dc.date.accessioned2019-03-19T11:47:24Z
dc.date.accessioned2019-03-21T11:37:31Z
dc.date.available2019-03-19T11:47:24Z
dc.date.available2019-03-21T11:37:31Z
dc.date.issued2018-09-18
dc.identifier.citationSvendsen KS, Jacobs Jr. DR, Røyseth, Garstad KW, Byfuglien MG, Granlund L, Mørch-Reiersen LT, Telle-Hansen VH, Retterstøl K. Community pharmacies offer a potential high-yield and convenient arena for total cholesterol and CVD risk screening.. European Journal of Public Health. 2018;0(0):1-6en
dc.identifier.issn1101-1262
dc.identifier.issn1101-1262
dc.identifier.issn1464-360X
dc.identifier.urihttps://hdl.handle.net/10642/6857
dc.description.abstractBackground: Moderately elevated blood total cholesterol (TC), blood glucose (BG) and blood pressure (BP) are rarely symptomatic and as such many individuals remain untreated. We studied the yield of an in-pharmacy screening for identifying undetected high TC and strategies to reach those with absence of prior measurement of TC, BG and BP. Methods: A cross sectional TC screening study with complementary TC measurements and self-administered questionnaire was conducted for one week in each of 2012 and 2014 in 148 and 149 BootsTM Norge AS community pharmacies nationwide in Norway. Results: Non-medicated adults (n=21090) with mean age 54.5±16.0 were included. The study population resembled the Norwegian population in regards to body mass index, educational level, smokers and physical inactivity level, but with an overrepresentation of middle-aged women. Of 20 743 with available data, 11% (n=2337) were unaware of their high TC ≥7.0 mmol/L, and an additional 8% were unaware of TC ≥6.2 mmol/L. >40% of the study sample had not measured TC or BG before. In order for future screenings to reach those that are less likely to have previously measured TC and BG, our results suggest that young, low-educated, overweight men and women should be targeted for TC measurement, whereas normal weigh men in all ages should be targeted for BG measurement. Conclusions: In total 19% in an in-pharmacy screening were unaware of their elevated TC of ≥ 6.2 mmol/L. We also identified characteristics that could be used reach those who are less likely to have measured TC and BG.en
dc.description.sponsorshipThis study was supported by the University of Oslo, Mills AS and Boots Norge AS. Mills contributed with funding used to optical reading of questionnaires. Boots pharmacies contributed with expenses related to staff, advertisement and all equipment needed for the TC tests. Mills and Boots contributed financially to advertisement of the screening. Mills sponsored the optical reading of questionnaires.en
dc.language.isoenen
dc.publisherOxford University Pressen
dc.relation.ispartofseriesEuropean Journal of Public Health;Volume 29, Issue 1, 1 February 2019
dc.rightsThis is a pre-copyedited, author-produced version of an article accepted for publication in European Journal of Public Health following peer review. The version of record Karianne Svendsen, David R Jacobs Jr, Ida Tonning Røyseth, Kjersti Wilhelmsen Garstad, Marte Gjeitung Byfuglien, Linda Granlund, Lisa T Mørch-Reiersen, Vibeke H Telle-Hansen, Kjetil Retterstøl; Community pharmacies offer a potential high-yield and convenient arena for total cholesterol and CVD risk screening, European Journal of Public Health, Volume 29, Issue 1 is available online at: https://academic.oup.com/eurpub/article/29/1/17/5100739 / http://dx.doi.org/10.1093/eurpub/cky190en
dc.subjectScreeningsen
dc.subjectCommunity pharmaciesen
dc.subjectCholesterol-yielden
dc.subjectCardiovascular diseasesen
dc.subjectCholesterolen
dc.titleCommunity pharmacies offer a potential high-yield and convenient arena for total cholesterol and CVD risk screening.en
dc.typeJournal articleen
dc.typePeer revieweden
dc.date.updated2019-03-19T11:47:24Z
dc.description.versionacceptedVersionen
dc.identifier.doihttp://dx.doi.org/10.1093/eurpub/cky190
dc.identifier.cristin1663016
dc.source.journalEuropean Journal of Public Health


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel